Arrive AI (NASDAQ:ARAI) Downgraded to “Sell” Rating by Wall Street Zen

Arrive AI (NASDAQ:ARAI) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e)” rating on shares of Arrive AI in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Arrive AI has an average rating of “Hold” and an average price target of $12.00.

Arrive AI Price Performance

Shares of NASDAQ:ARAI opened at $1.03 on Friday. The stock has a market cap of $35.24 million and a price-to-earnings ratio of -5.42. The company has a 50 day moving average of $1.92 and a 200-day moving average of $3.43. Arrive AI has a one year low of $0.96 and a one year high of $40.00.

Hedge Funds Weigh In On Arrive AI

Hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC acquired a new stake in Arrive AI in the 2nd quarter worth about $793,000. Rockefeller Capital Management L.P. acquired a new stake in Arrive AI during the second quarter worth about $607,000. OMERS ADMINISTRATION Corp bought a new position in Arrive AI in the 2nd quarter valued at about $543,000. Tower Research Capital LLC TRC bought a new position in Arrive AI in the 2nd quarter valued at about $133,000. Finally, New York State Common Retirement Fund bought a new stake in Arrive AI during the third quarter worth $45,000.

About Arrive AI

We were incorporated on April 30, 2020, in the State of Delaware under the name of Dronedek Corporation. The Company changed its name to Arrive Technology Inc on July 27, 2023. The Company changed its name to Arrive AI Inc on September 30, 2024. We are a developmental technology company with a focus on designing and implementing a commercially viable smart mailbox and platform system for smart, secure, and seamless exchange of packages, goods, supplies, food, and medications between people, through the use of robots, and drones.